Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Avecho Biotechnology Limited ( (AU:AVE) ) is now available.
Avecho Biotechnology Limited has scheduled its Annual General Meeting for Tuesday, 26 May 2026 at 1:00pm AEST, to be held at Grant Thornton’s offices in Collins Square, Melbourne. Shareholders are encouraged to participate either in person or by lodging proxies electronically, with proxy forms required to be received by 1:00pm AEST on Sunday, 24 May 2026.
In line with provisions of the Corporations Act 2001, the company will not circulate hard copies of the Notice of Meeting or Explanatory Statement unless shareholders specifically elect to receive paper materials. These AGM documents are available via the ASX announcement platform and the company’s website, reinforcing Avecho’s shift toward digital shareholder communication and streamlined meeting administration.
More about Avecho Biotechnology Limited
Avecho Biotechnology Limited is an Australian biotechnology company, though this notice does not detail its specific products, services, or market focus. The company is listed on the Australian Securities Exchange and engages with shareholders under the Corporations Act 2001 framework, utilising electronic communications for corporate governance and meeting materials.
Average Trading Volume: 6,062,319
Technical Sentiment Signal: Sell
Current Market Cap: A$34.9M
Learn more about AVE stock on TipRanks’ Stock Analysis page.